Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT02174926
Other study ID # LASERtrial
Secondary ID
Status Active, not recruiting
Phase N/A
First received
Last updated
Start date September 2014
Est. completion date December 2027

Study information

Verified date August 2020
Source Helsinki University Central Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to find out whether elective sigmoid resection will improve quality of life compared to conservative treatment with lifestyle guidance and fiber supplement in patients with a recurrent or complicated diverticulitis.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 133
Est. completion date December 2027
Est. primary completion date April 2019
Accepts healthy volunteers
Gender All
Age group 18 Years to 75 Years
Eligibility Inclusion Criteria:

- Recurrent left colon diverticulitis (minimum 3 within 2 years, at least 1 confirmed with CT)

OR

- Earlier complicated left colon diverticulitis

OR

- Prolonged (over 3 months) pain or disturbance in bowel habits after a CT-confirmed left colon diverticulitis

Exclusion Criteria:

- Multimorbidity that prevents elective surgery

- Contraindication to laparoscopy

- Colonic stricture

- Fistula (e.g. colocutaneous, colovaginal, colovesical)

- Active malignancy

- Earlier resection of sigmoid colon or rectum

- Acute diverticulitis that has not settled

- Colonoscopy/sigmoidoscopy/virtual colonoscopy not performed within 2 years

- Age < 18 or > 75 years

- Pregnancy

- Inability to answer health surveys (e.g. dementia, psychiatric condition)

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Elective laparoscopic sigmoid resection

Dietary Supplement:
Conservative treatment
Written lifestyle guidance and fiber supplements

Locations

Country Name City State
Finland Helsinki University Central Hospital, Jorvi Hospital Espoo
Finland Kanta-Häme Central Hospital Hämeenlinna
Finland Helsinki University Central Hospital Helsinki
Finland North Carelia Central Hospital Joensuu
Finland Keski-Suomi Central Hospital Jyväskylä
Finland Kuopio University Central Hospital Kuopio
Finland Päijät-Häme Central Hospital Lahti
Finland Oulu University Hospital Oulu
Finland Etelä-Pohjanmaa Central Hospital Seinäjoki
Finland Turku University Central Hospital Turku
Finland Vaasa Central Hospital Vaasa

Sponsors (1)

Lead Sponsor Collaborator
Helsinki University Central Hospital

Country where clinical trial is conducted

Finland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Gastrointestinal quality of life-index change at 6 months Difference in gastrointestinal quality of life-index (GIQLI) at randomization and 6 months from randomization. 6 months from randomization
Secondary GIQLI at 12, 24, 48, and 96 months 12, 24, 48, and 96 months from randomization
Secondary Short form (SF) 36 Health survey score at 6, 12, 24, 48, and 96 months 6, 12, 24, 48, and 96 months from randomization
Secondary Recurrence and severity of recurrent diverticulitis 0 - 96 months from randomization
Secondary Need of emergency surgery due to diverticulitis Whether or not patient has undergone emergency surgery due to diverticulitis during follow-up period. Assessment will be carried out by patient questionnaire and search for patient records. 0 - 96 months from randomization
Secondary Need of elective sigmoid resection due to diverticulitis (conservative arm) Whether or not patient has undergone elective sigmoid resection due to diverticulitis during follow-up period. Assessment will be carried out by patient questionnaire and search for patient records. 0 - 96 months from randomization
Secondary Complications due to elective sigmoid resection 0 - 96 months from randomization
Secondary Mortality 0 - 96 months
Secondary Complications of diverticular disease 0 - 96 months
Secondary Stoma rate 0 - 96 months from randomization
See also
  Status Clinical Trial Phase
Completed NCT01682395 - Best Management of Sigmoid Volvulus: A Prospective Randomized Trial N/A
Recruiting NCT02222844 - Improving Radical Treatment Through MRI Evaluation of Pelvic Sigmoid Cancers N/A